ArticleCPT: pharmacometrics & systems pharmacology2023

Population pharmacokinetic and exposure-response analyses of pemigatinib in patients with advanced solid tumors including cholangiocarcinoma.

Xiaohua Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.